Wa'El Hashad

Wa'el Hashad currently serves as a Member of the Board of Directors at Akari Therapeutics, Plc, and as the Chief Executive Officer and Member of the Board at Longeveron Inc. Previously, Wa'el Hashad held significant leadership roles, including President and CEO at Avanir Pharmaceuticals and Executive Vice President and Chief Commercial Officer at Seres Therapeutics. Wa'el Hashad's extensive experience at Amgen involved several vice president positions overseeing marketing and commercial development across diverse regions. Other noteworthy positions include Vice President of the Cardiovascular Business Unit at Eli Lilly and Vice President of Commercial Operations at Boehringer Ingelheim. Wa'el Hashad holds an MBA from The University of Akron and a B.Sc. in Pharmacy from Cairo University.